Introduction
============

At high altitude (HA) hypobaric hypoxia causes a decrease in the partial pressure of inspired oxygen and leads to low availability of oxygen in the body, which reduces fitness and can affect survival (Frisancho [@b28]). However, other stressors such as increased radiation, aridity, broader temperature ranges, and poorer diets may also affect developmental characteristics in these environments (Leonard [@b41]; West et al. [@b72]; Pomeroy et al. [@b54]). Evidence for HA adaptation was shown in Tibetans (Beall et al. [@b9]; Bigham et al. [@b12]; Yi et al. [@b74]; Peng et al. [@b51]; Simonson et al. [@b63]), Andeans (Beall et al. [@b8]; Bigham et al. [@b11], [@b12]; Zhou et al. [@b75]; Eichstaedt et al. [@b23]), and Ethiopians (Alkorta-Aranburu et al. [@b3]; Scheinfeldt et al. [@b62]; Huerta-Sanchez et al. [@b38]; Udpa et al. [@b69]), thus demonstrating the effects of long-term exposure to hypoxia above 3000 m. However, little is known about the effects of moderate levels of hypoxia on human physiology, such as those found at intermediate altitudes (IA), which we define hereafter as altitudes between 2000 and 3000 m. Some indication that moderate hypoxia may have a physiological impact comes from evidence of an albeit modest occurrence of Acute Mountain Sickness (AMS), High Altitude Pulmonary Edema (HAPE) (West et al. [@b72]), and birth weight reduction (Mortola et al. [@b48]) just above 2000 m.

There is deep academic interest in the physiology of HA due to its obvious medical relevance; yet, the understanding of the cellular and molecular mechanisms that underlie the physiological response to hypobaric hypoxia remains patchy. We also need to better understand the interplay between hypobaric hypoxia and other co-occurring environmental and socioeconomic stressors, and between phenotypic plasticity and genetic adaptation (Storz et al. [@b66]). The latter was suggested by a number of studies (Alkorta-Aranburu et al. [@b3]; Simonson et al. [@b63]; Bigham et al. [@b13]; Eichstaedt et al. [@b23]), and even reported to occur at IA (Pagani et al. [@b49]; Huerta-Sanchez et al. [@b38]). However, the functional relevance of these genomic signatures remains largely unassessed.

Given these knowledge gaps, we recently investigated patterns of adaptation to HA in the Collas of Northwest Argentina who live above 3500 m (Eichstaedt et al. [@b23]). Here, we present phenotypic and genetic data from an intermediate altitude (IA) Andean population at 2300 m, the Calchaquíes. These people inhabit the Calchaquí Valleys, a region bordering the high plateau of the Central Andes in Argentina and characterized by a mild and dry climate (average air temperature in coldest month: 7°C, warmest month: 21°C) (Bianchi and Cravero [@b10]). This gives us the opportunity to assess the impact of moderate levels of hypoxia upon the organism largely without the confounding effects of other environmental stressors.

Remarkably, there are major adaptive differences between Andeans, Tibetans, and Ethiopians at the phenotypic level. For example, the typical physiological response to hypoxia in Andean highlanders is an increased hematocrit, extended lung volume, blunted hypoxic ventilatory response, and increased pulmonary diffusion (Rupert and Hochachka [@b60]). At the morphological level, Andeans also show a larger chest and greater lung volume (Brutsaert et al. [@b15]). At the same time height is reduced, thus increasing the ratio of ventilatory capacity to body mass (Guyton and Hall [@b34]). Fetal growth restriction in Andeans and Tibetans is limited in comparison to nonnative highlanders born at HA (Giussani et al. [@b32]; Moore et al. [@b47]). At the cellular level, the vasodilator nitric oxide (NO) in exhaled breath is 28% elevated in Andeans compared to sea-level values (Beall [@b6]). Tibetans show even higher values of exhaled NO (Beall [@b6]; Erzurum et al. [@b25]), higher alveolar ventilation (Zhuang et al. [@b76]), no hypoxia induced pulmonary vascular resistance response (Groves et al. [@b33]) and only minimally increased hemoglobin concentrations (Beall [@b7]). Ethiopians, on the other hand, display a physiology barely distinguishable from lowlanders with only slightly increased hematocrit (Scheinfeldt et al. [@b62]), elevated pulmonary arterial pressure and permanently high pulmonary blood flow (Hoit et al. [@b36]). These different adaptive solutions to hypoxia, suggest convergent evolutionary pathways (Scheinfeldt et al. [@b62]) and underline the critical importance of hypoxia as an environmental pressure.

Despite this extensive literature, most of the knowledge comes from the study of HA populations, thus it remains unclear whether the same traits have developed under moderate hypoxia. Therefore, our focus on the Calchaquíes allows us to investigate for the first time phenotypic and genetic adaptations in an Andean population at IA, although this is not without challenges. For a start, Calchaquíes are thought to be closely related to other HA populations (Frank [@b27]), yet their demographic history is poorly researched. The Calchaquíes belong to the Diaguita group of small tribes scattered predominantly in the valleys of Northwest Argentina (1680--3015 m) (De Hoyos [@b22]). Archeological evidence around the Calchaquí valleys suggest that settlement dates back to 7200 (Rodríguez et al. [@b59]) and 6500 years ago (Somonte and Baied [@b64]). Moreover, the region was a migration corridor during the Inca expansion in the XV century; yet, the extent of gene flow that took place at that time is largely unknown. This dearth of population history can potentially complicate the disentangling of demographic and adaptive signals.

From the current HA literature we identify a need for further data to improve our understanding of (i) what are the threshold levels of hypobaric hypoxia with a significant effect on human physiology and development, (ii) whether the same or different mechanisms are triggered by strong and moderate hypoxia, and (iii) whether moderate hypoxia represents a selective pressure strong enough to leave a genomic signature. In order to address these questions we attempt to assess phenotype-genotype correlations by examining, alongside our genome-wide selection tests, a number of anthropometric, and physiological characteristics. In particular, we highlight one candidate gene of selection involved in the NO pathway, as well as physiological and anatomical patterns that could be part of the biological response to the effects of moderate hypoxia.

Methods
=======

Subjects and ethical approval
-----------------------------

The Calchaquí Valleys lie at intermediate altitude (IA, 2000--3000 m) in the middle of an altitude gradient between the Andean highlands to the West and the Gran Chaco plains to the East (Fig.[1](#fig01){ref-type="fig"}). From both of these regions we include a reference population (Collas and Wichí), which has been described elsewhere (Eichstaedt et al. [@b24]). Our final dataset consisted of 44 Wichí (low altitude, LA, ca. 300 m; 26 females, 18 males), 60 Calchaquíes (IA, 2326 m; 40 females, 20 males), and 75 Collas (HA, \>3500 m; 49 females, 26 males), totaling 179 indigenous Argentinean individuals. We only included unrelated adult individuals (\>18 years), who were born and raised at the respective altitude and excluded pregnant or lactating women. Ethnicity was self-identified and long-term ancestry was confirmed by identifying birthplaces of participants, their parents, and grandparents. We briefly interviewed each participant to assess general health, age, and the time and type of the last meal. Contents of the meal were assessed in terms of calories with the national nutrient program USDA Food Search (U.S. Department of Agriculture [@b70]). The total amount of calories of the last meal was added as a variable to the dataset to account for the effects of postprandial hypotension on the physiological measurements taken. Finally, we measured anthropometric and physiological traits and collected saliva samples for genotyping.

![Range of birthplaces of participants and their ancestors in the three regions. Dots on the map are roughly proportional to the number of individuals born in one location. The maximum extent is displayed as circles: 94 Calchaquí participant (IA) ancestors were born in Cachi, 43 Colla participant (HA) ancestors in San Antonio de los Cobres. Stars denote sampling locations. The third purple star from left indicates Misión Chaqueña. HA, high altitude; LA, low altitude; IA, intermediate altitude.](phy20003-e12376-f1){#fig01}

The study was approved by the Ethics Committee at the University of East Anglia and the Ministry of Health of the Province of Salta (Ministerio de Salud Pública, Salta, Argentina). All individuals gave written informed consent before taking part in the study. Additional ethical approval for genotyping of the samples at Cambridge Genomic Services was obtained from University of Cambridge Human Biology Research Ethics Committee (HBREC.2011.01).

Demographic analyses
--------------------

Saliva sample collection, DNA extraction, and genotyping conditions have been reported elsewhere (Eichstaedt et al. [@b23]). We chose a subset of 24 Calchaquí (IA) samples with the highest DNA concentrations for genotyping with the Illumina HumanOmniExpress BeadChip for 730,000 Single Nucleotide Polymorphisms (SNPs) for comparison with the previously reported Colla and Wichí samples genotyped using the same platform (Eichstaedt et al. [@b23]). One lowland sample was excluded due to 50% European admixture and seven samples due to unreported consanguinity. This resulted in a total sample of 20 Wichí, 23 Calchaquí, and 23 Collas being included for genomic analyses. The newly generated Calchaquí sequences (IA) were deposited with NCBI GEO under accession numbers (GSM1363137-GSM1363160).

In order to assess ancestry we surveyed uniparental markers, mitochondrial DNA (mtDNA), and Y-chromosome (Y-chr). We sequenced the hypervariable region I of the mtDNA, between positions 15,908 and 16,498, to identify mitochondrial haplogroups using published primers and protocols (Sykes et al. [@b67]; Hill et al. [@b35]). For the Y-chr, we used restriction length polymorphisms (RFLP) to assign samples to Y-chr haplogroups. RFLP analysis for the Native American haplogroups Q and C and European haplogroup R1b, J and K (Corach et al. [@b21]) were carried out as previously described (Eichstaedt et al. [@b23]).

We used the software PLINK (Purcell et al. [@b56]) to determine a set of autosomal SNPs shared between our Calchaquí sample and the following populations: Karitiana, Suruí, Pima, and Colombians from the Human Genome Diversity Project (HGDP) (Li et al. [@b42]), Han Chinese and Utah residents from the HapMap project (International HapMap-Consortium [@b39]), Aymara and Quechua published by Mao et al. ([@b44]), Wichí and Collas from Eichstaedt et al. ([@b23]), and a subset of Native American populations (Reich et al. [@b58]). The final dataset for this ancestry analysis consisted of 17,374 shared SNPs in random association (*r*^2^ \< 0.1). We cleaned and phased the data as previously described (Eichstaedt et al. [@b23]). We obtained admixture proportions using the program ADMIXTURE (Alexander et al. [@b2]). We performed 100 iterations for *K* values 2--10 to analyze each genome for a given number of potential ancestors. The *K* with the smallest cross-validation error was chosen as the best fit for the data (Alexander and Lange [@b1]). The same set of SNPs was used for Principal Component Analysis (PCA) using the SmartPCA function implemented in the EIGENSOFT package (Patterson et al. [@b50]) and to generate genome-wide heterozygosity estimates with the program PLINK.

Phenotypic measurements
-----------------------

We measured anthropometric traits previously reported to show considerable differences in highland populations: height, sitting height, tibia length, weight, forearm length, and hip circumference. These traits were measured following Frisancho ([@b29]) and Cameron ([@b17]). Height and sitting height were recorded with a stadiometer (Leicester Height Measure, Seca, UK) and weight was recorded with a bio-impedance scale (Body Composition Meter BC-520, Tanita, USA). Hip circumference was measured with tape at the maximum extension of the buttocks (Chasmors Ltd., London, UK) and was used to correct for buttocks soft tissue (Bogin and Varela-Silva [@b14]). The ratio of height to sitting height was used as a proxy for lower extremity length and body proportions (Martin et al. [@b45]). Relative subischial leg length (RSLL) was calculated as follows: RSLL = (height − sitting height)/height\*100; the lower the RSLL is, the shorter are the legs. Knee height was taken as a proxy for tibia length and forearm length was measured between the styloid process of the ulna and the maximum extension of the elbow. BMI was calculated as weight/(height)^2^. Oxygen saturation and heart rate were measured simultaneously with a digital pulse oximeter (model 8500; Nonin Medical Inc., Plymouth, MN). Values were recorded once they remained stable for at least 10 sec. Respiration rate was determined by counting the number of breaths per minute with the participant seated in a comfortable position. Of these variables, height, weight, BMI, heart rate, respiration rate, and oxygen saturation have been reported previously for a subset of Collas and Wichí included here (Eichstaedt et al. [@b23]).

Lung function was assessed using a portable spirometer (SpiroPro; CareFusion, Hoechberg, Germany) with disposable mouthpieces (Air Safety Ltd., Morecambe, UK), calibrated daily prior to use. Volume and flow measurements were automatically corrected for body temperature, ambient pressure, and water vapor saturation (BTPS). Procedures were performed according to the guidelines of the American Thoracic Society and European Respiratory Society (ATS/ERS). The highest measurement of at least three attempts of vital capacity (VC), forced vital capacity (FVC), the forced expiratory volume (FEV~1~), and the peak expiratory flow (PEF) were recorded. Reference values for each participant were obtained for the respective gender, height, and age (Quanjer et al. [@b57]). We created a variable to distinguish healthy individuals from those with reported medical conditions or life style conditions potentially affecting lung function. Thus, participants with acute cold or bronchitis (*n *= 14), alcohol problems (*n *= 1), chest pain during breathing (*n *= 10), dyspnea (*n *= 3), as well as heavy smokers (≥30 cigarettes a month, *n *= 13), were considered "lung affected". Among the Calchaquíes, 11 individuals were affected (18%), 11 Collas (15%), and 19 Wichí (43%). This variable was considered in all statistical assessments of lung performance.

Phenotypic data were analyzed with SPSS Statistics 21., IBM Corp., New York. We used one-way analysis of variance (ANOVA) to compare continuous and categorical phenotypic variables between the three altitude groups. Levene\'s homogeneity test was used to determine whether variances were equal. For equal variances Hochberg\'s GT2 post hoc test was considered, whereas unequal variances were corrected using the Games-Howell post hoc test. The influence of a given independent variable (IV) on a continuous dependent variable (DV) was assessed by type I General Linear Model (GLM). Bonferroni correction was applied to account for multiple testing. Pairwise comparisons of the estimated marginal means of the DV were made with means adjusted for other covariates, that is, continuous variables included in the model.

Tests for positive selection
----------------------------

We used four different tests (integrated Haplotype Score, iHS; Cross Population Extended Haplotype Homozygosity, XP-EHH; Population Branch Statistic, PBS and the Fixation Index, *F*~ST~) to screen for empirical outliers in our data likely driven by natural selection following the methods described previously (Weir and Cockerham [@b71]; Sabeti et al. [@b61]; Pickrell et al. [@b52]; Yi et al. [@b74]; Eichstaedt et al. [@b23]). Similar to Pickrell et al. ([@b52]), we used 200 kb windows in iHS and XP-EHH scans binned by SNP numbers to compensate for unequal SNP distribution in the Illumina OmniExpress SNP-chip data. The top 1% windows of iHS in Calchaquíes were only considered if they were not among the top 5% of Wichí iHS windows. *F*~ST~ and PBS tests, which emphasize maximum SNP values, were performed on 100 kb windows using lowland Wichí population from Argentina and Siberian Eskimos, NCBI GEO series number GSE55586, (Cardona et al. [@b18]) as outgroups. The top 1% windows of all four tests were compared to an a priori candidate gene list (*n* = 213) details specified in Table S2, Eichstaedt et al. ([@b23]) to identify genes closely implicated in hypoxia response. The top 1% was chosen as a conservative cut-off, compared to 5% used in other studies investigating Andean genetic adaptations (Bigham et al. [@b11], [@b12]). The candidate genes were based on gene ontology (GO) terms associated with hypoxia response ("Cellular response to hypoxia" and "Cellular response to ROS") and REACTOME pathways ("NO stimulates guanylate cyclase", "Metabolism of angiotensinogen to angiotensins" and "VEGF signaling"). All genes related to these pathways were included in the final candidate gene list. While further pathways are involved in the hypoxia response we only focused on those potentially most relevant to Andean phenotypes such as an increased hematocrit, blood flow regulations, and vascularization, albeit keeping the number of candidate genes to a minimum. This list is not exhaustive and other pathways might also be relevant; however, we decided to limit genes to a minimum due to the paucity of relevant functional genetic variations in Andeans. Allele frequencies of highly distinct alleles highlighted by PBS were investigated in the three Argentinean populations using GLM test in SPSS. Genes in the top 1% windows of iHS, XP-EHH, and PBS were screened for enrichment of functional categories by GO terms using the Expression Analysis Systematic Explorer (EASE) score \<0.01. The EASE score is a conservative adjustment of Fisher\'s exact *P*-value implemented in DAVID and more robust for pointing out enriched biological functions (Hosack et al. [@b37]).

Results
=======

Genetic structure and recent admixture in Andean populations
------------------------------------------------------------

Places of birth of participants, their parents, and grandparents were used to ascertain long-term residency at each sampling altitude (Fig.[1](#fig01){ref-type="fig"}). Admixture analyses were conducted to estimate the extent of recent European gene flow in our sample and to assess genetic differentiation between Calchaquíes (intermediate altitude, IA), other Andean populations, and Native Americans in general (Fig.[2](#fig02){ref-type="fig"}). Cross-validation (CV) error and log-likelihood difference indicated *K* = 6 as the best fit for the data. *K* refers to the number of ancestry components or distinct putative ancestors that best explain the observed genomic diversity in the included set of populations. The autosomal European admixture proportion in the Calchaquí population was estimated as 9% on average (Table[1](#tbl1){ref-type="table"}). Admixture patterns in Calchaquíes resemble other Andean populations such as Quechua (HA), Aymara (HA), Collas (HA), and Diaguita (IA) (Fig.[2](#fig02){ref-type="fig"}). Calchaquíes show the highest heterozygosity of all analyzed Native American populations at 28% (lowest heterozygosity found in Brazilian Suruí with 22% and a mean of 26% across Native American populations, data not shown). This is partly accounted for by the high levels of autosomal European admixture but also indicating lower levels of inbreeding and genetic drift.

###### 

Autosomal admixture estimates at *K* = 6 in Argentineans

  Admixture   Wichí (LA), %   Calchaquíes (IA), %   Collas (HA), %
  ----------- --------------- --------------------- ----------------
  Mean        2.7             8.6                   5.0
  Median      0.0             8.6                   4.9
  Range       0.0--20.9       4.1--20.7             0.0--9.5

![Admixture proportions of Calchaquíes among Native Americans, Han Chinese, and Europeans at *K* = 6. Ancestry components are assigned to each individual. Cross-validation error was the lowest for *K* = 6, which indicates that the population structure observed among the included populations is best explained by 6 distinct ancestry components. Han Chinese, Europeans, Pima, Suruí, Andeans (HA and IA), and Wichí (LA) are characterized by a unique ancestry components; that is, the program assumes a major genetic contribution from separate ancestors for each of these populations. Mixe from Mexico, Piapoco from Colombia, Kaqchikel from Guatemala, and Karitiana from Brazil share the same four Native American admixture components in similar proportions. Chileans (Hul/Chi/Cho/Yag: Hulliche, Chilote, Chono, and Yaghan) display the same four components but the Andean ancestry component accounts for more than 50%. Populations from the Gran Chaco region other than Wichí (Cha/Kai/Gua/Tob: Chané, Kaingang, Guaraní, and Toba) share more than 30% of the Wichí ancestry component.](phy20003-e12376-f2){#fig02}

We performed Principal Component Analysis (PCA) to examine population differentiation. The resulting clustering roughly describes three broad geographic areas (Fig.[3](#fig03){ref-type="fig"}): (i) Northwest Argentina including Calchaquíes (this study), highland Collas (Eichstaedt et al. [@b23]) and Diaguita from an IA (Reich et al. [@b58]); (ii) Peruvian Quechua (Mao et al. [@b44]); and (iii) Bolivian and Northern Chilean Aymara (Mao et al. [@b44]; Reich et al. [@b58]). The Quechua dataset from Reich et al. ([@b58]) overlapped with the latter two groups because it includes individuals from Bolivia and Peru, suggesting that geography plays a greater role than reported ethnicity in determining the genetic structure of Andean populations.

![PCA of neighboring Andean populations. Circles denote individuals from Mao et al. ([@b44]); triangles refer to this study, diamonds to Eichstaedt et al. ([@b23]), and rectangles to Reich et al. ([@b58]). (A) Samples overlap but cluster roughly according to geographic origin: populations in the left circle stem from Peru (HA), in the bottom circle from Bolivia and Chile and in the right circle from Argentina (HA and IA). Due to unknown precise sampling locations Quechua individuals sampled by Reich et al. ([@b58]) cannot be assigned to one specific country. However, it is likely that Quechua from Peru cluster with Peruvian Quechua sampled by Mao et al. ([@b44]) and Quechua from Bolivia overlap with Bolivian Aymara. (B) The same samples except for Quechua and Aymara from Reich et al. ([@b58]) with unclear geographic origin were included, showing a clustering by geographic origin apart for one Peruvian Quechua individual.](phy20003-e12376-f3){#fig03}

As autosomal genotype data were only available for a subset of our sample, we analyzed the mitochondrial control region and the Y-chr to investigate haplogroup distribution in the entire dataset and thus obtained complementary ancestry information. All 179 samples clustered within Native American mtDNA haplogroups (Table[2](#tbl2){ref-type="table"}). While the majority of Calchaquí Y-chr (80%) belonged to haplogroup Q, which is common Native Americans, a minor subset (20%) of the samples showed affinities to haplogroups that are common in Europe (Table[2](#tbl2){ref-type="table"}).

###### 

Mitochondrial DNA and Y-chromosome haplogroups among Argentineans

  Marker                                Haplogroup   Wichí (LA) (%)   Calchaquíes (IA) (%)   Collas (HA) (%)
  ------------------------------------- ------------ ---------------- ---------------------- -----------------
  Mitochondrial DNA                     A            0                0                      1 (1.3)
  A2[\*](#tf2-1){ref-type="table-fn"}   11 (25.0)    9 (15.0)         13 (17.3)              
  B2                                    19 (43.2)    34 (56.7)        49 (65.3)              
  C1                                    0            5 (8.3)          4 (5.3)                
  D1                                    14 (31.8)    11 (18.3)        8 (10.7)               
  D4h3a                                 0            1 (1.7)          0                      
  Y-chromosome                          Q            16 (88.9)        16 (80.0)              19 (73.1)
  R1b                                   2 (11.1)     3 (15.0)         6 (23.1)               
  J                                     0            0                1 (3.8)                
  E1b1b1b                               0            1 (5)            0                      

This haplogroup is a paragroup of A2.

Phenotypic traits characteristic to an intermediate altitude population in the Andes
------------------------------------------------------------------------------------

We assessed the effect of altitude on anthropometric and physiological variables (Table[3](#tbl3){ref-type="table"}). Height was not significantly different between groups but weight and BMI were elevated in Wichí. Sitting height as a proxy for torso length showed no difference between groups, whereas tibia length (approximated by knee height) and forearm lengths were similar in Calchaquíes and Wichí, but significantly reduced in Collas. The whole leg length variation was measured as relative subischial leg length (RSLL). Significant differences were only observed between Collas (HA) and Wichí (LA).

###### 

Phenotypic differences between Wichí, Calchaquíes, and Collas

  Dependent variable                           Wichí (LA, *n* = 44)   Calchaquíes (IA, *n* = 60)   Collas (HA, *n* = 75)   Pairwise comparison[\*](#tf3-1){ref-type="table-fn"}   Model information[†](#tf3-2){ref-type="table-fn"}
  -------------------------------------------- ---------------------- ---------------------------- ----------------------- ------------------------------------------------------ -----------------------------------------------------
  Age (years)                                  42.1±14.1              45.9±14.4                    42.6±13.6               1: *P*=n.s.                                            Model: *P*=n.s.
                                                                                                                           2: *P*=n.s.                                            ANOVA
                                                                                                                           3: *P*=n.s.                                            
  Height (cm)                                  159.3±8.4              158.0±9.1                    157.5±8.1               1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*=n.s.                                            adjusted *R*^2^: 64.1%
                                                                                                                           3: *P*=n.s.                                            IVs: Gender, age
  Weight (kg)                                  74.5±15.7              65.8±13.2                    65.5±12.5               1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*=0.008                                           adjusted *R*^2^: 15.1%
                                                                                                                           3: *P*=0.002                                           IVs: Gender, age
  Body mass index (m^2^/kg)                    29.4±5.9               26.3±4.2                     26.4±4.5                1: *P*=n.s.                                            Model: *P*=0.002
                                                                                                                           2: *P*=0.002                                           adjusted *R*^2^: 7.2%
                                                                                                                           3: *P*=0.003                                           IVs: Gender, age
  Sitting height (cm)                          82.0±4.2               81.9±4.3                     82.3±4.1                1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*=n.s.                                            adjusted *R*^2^: 52.2%
                                                                                                                           3: *P*=n.s.                                            IVs: Gender, age, hip circumference
  Knee height (cm)                             49.3±3.0               48.4±3.5                     46.7±3.3                1: *P*\<0.001                                          Model: *P*\<0.001
                                                                                                                           2: *P*=n.s.                                            adjusted *R*^2^: 54.4%
                                                                                                                           3: *P*\<0.001                                          IVs: Gender, age, sitting height, hip circumference
  Forearm length (cm)                          25.6±1.9               25.0±2.2                     24.5±1.6                1: *P*=0.028                                           Model: *P*\<0.001
                                                                                                                           2: *P*=n.s.                                            adjusted *R*^2^: 80.3%
                                                                                                                           3: *P*\<0.001                                          IVs: Gender, age, height
  Relative subischial leg length (%)           48.5±1.6               48.1±1.5                     47.7±1.4                1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*=n.s.                                            adjusted *R*^2^: 15.8%
                                                                                                                           3: *P*=0.014                                           IVs: Gender, age
  Heart rate                                   74.3±11.0              70.3±9.0                     71.2±10.5               1: *P*=n.s.                                            Model: *P*=n.s.
                                                                                                                           2: *P*=n.s.                                            adjusted *R*^2^: 0.2%
                                                                                                                           3: *P*=n.s                                             IVs: Gender, age
  Oxygen saturation (%)                        97.1±1.2               92.7±2.4                     87.4±3.2                1: *P*\<0.001                                          Model: *P*\<0.001
                                                                                                                           2: *P*\<0.001                                          adjusted *R*^2^: 72.6%
                                                                                                                           3: *P*\<0.001                                          IVs: Gender, age
  Respiration rate                             17.5±4.6               18.3±3.3                     21.1±5.6                1: *P*=0.001                                           Model: *P*\<0.001
                                                                                                                           2: *P*=n.s.                                            ANOVA, unequal variances
                                                                                                                           3: *P*=0.001                                           corrected
  Vital capacity (L)                           2.6±1.0                2.9±1.0                      2.9±1.1                 1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*=0.005                                           adjusted *R*^2^: 48.5%
                                                                                                                           3: *P*=0.015                                           IVs: Gender, age, height
  Forced vital capacity (L)                    2.9±1.0                3.2±1.0                      3.4±0.9                 1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*=0.022                                           adjusted *R*^2^: 60.4%
                                                                                                                           3: *P*\<0.001                                          IVs: Gender, age, height, lung health
  Forced expiratory volume in 1st second (L)   2.6±0.9                2.9±0.9                      3.0±0.8                 1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*\<0.001                                          adjusted *R*^2^: 70.2%
                                                                                                                           3: *P*\<0.001                                          IVs: Gender, age, height, lung health
  Peak expiratory flow (L/min)                 4.6±2.0                6.3±2.3                      6.1±2.3                 1: *P*=n.s.                                            Model: *P*\<0.001
                                                                                                                           2: *P*\<0.001                                          adjusted *R*^2^: 57.8%
                                                                                                                           3: *P*\<0.001                                          IVs: Gender, age, height, lung health

Pairwise comparisons: 1: Calchaquíes vs. Collas, 2: Calchaquíes vs. Wichí, 3: Collas vs. Wichí.

IVs = Independent variables; Levene\'s test for homogeneity of variances was nonsignificant, apart for heart rate (*P *= 0.034) and respiration rate (*P *= 0.017). Unequal variances were accounted for with the post hoc test Games-Howell in ANOVA. Gender and age had no significant influence on respiration rate. Values are means and standard variation.

Heart rate at rest was not significantly different between populations. Oxygen saturation reflected differences in exposure to hypobaric hypoxia at the respective altitudes (*P* \< 0.001, Table[3](#tbl3){ref-type="table"}). Calchaquíes and Wichí did not show significant differences in respiration rate while Collas exhibited a significantly elevated rate in comparison to both populations (*P* = 0.001, Table[3](#tbl3){ref-type="table"}). Lung function measurements for Calchaquíes were indistinguishable from Collas (Table[3](#tbl3){ref-type="table"}). However, both populations differed significantly from Wichí.

Haplotype homozygosity and allele differentiation patterns specific to Calchaquíes
----------------------------------------------------------------------------------

Three of the 213 predefined candidate genes (*CMA1,* rank 70; *NOS3,* rank 76; *AGAP3*, rank 76) were found in the top 1% of Calchaquí iHS results, which is, however, not significantly higher than the number of genes expected to be highlighted from a list of randomly chosen genes. Similarly, for XP-EHH only two genes (*TPM1,* rank 62; *ITPR1,* rank 100) from the candidate gene list were identified within regions of extended homozygosity and overall no significant enrichment of the hypoxia candidate genes could be observed in the top ranking windows of haplotype homozygosity tests.

In the results of the frequency based tests the pairwise *F*~ST~ of Calchaquíes and Wichí did not highlight any genes from the hypoxia candidate gene list. PBS, however, revealed three hypoxia genes among the top 1% (*PRKG1, CBS,* and *EPO*, see Table[4](#tbl4){ref-type="table"}). Again, this is not significantly different from what would be expected by chance (2.1 genes); however, the important NO pathway mediator *PRKG1* ranked 5th highest and thus deserves further consideration given an increased NO in exhaled breath in Andeans (Beall [@b6]). There were 61 genes highlighted by at least two tests in Calchaquíes, 11 of which were independently highlighted by the three tests iHS, XP-EHH, and PBS (*ACACB, AP1S1, CHKA, FOXN4, MUC12, MUC17, MUC3A, NDUFS8, SERPINE1, TCIRG1, TRIM56*).

###### 

Hypoxia related top 1% PBS genes in Calchaquíes

  Rank       Gene[\*](#tf4-1){ref-type="table-fn"}   Name                             Function                                                                                                            Hypoxia association               Window PBS ~MAX~: Gene PBS~MAX~
  ---------- --------------------------------------- -------------------------------- ------------------------------------------------------------------------------------------------------------------- --------------------------------- -------------------------------------------------
  5 and 38   *PRKG1*                                 Protein kinase, cGMP-dependent   Key enzyme in NO pathway, regulates platelet activation and adhesion, smooth muscle contraction, cardiac function   NO stimulates guanylate cyclase   0.836: 0.836; 0.663: also within the gene
  48         *CBS*                                   Cystathionine-beta-synthase      Protects neurons against hypoxic injury; regulates cerebral blood flow                                              Cellular response to hypoxia      0.631: 0.631
  264        *EPO*                                   Erythropoietin                   Regulates erythrocyte production                                                                                    Cellular response to hypoxia      0.469: 8 kb downstream (No SNP within the gene)

213 candidate genes: *ACE, ACE2, ADAM8, AGAP3, AGT, AJUBA, AKR1C3, AKT1, ANGPT4, ANKRD1, ANPEP, ANXA1, APEX1, APOA4, AQP1, ARG1, ARNT, ATP6AP2, ATP7A, BACH1, BAD, BBC3, BMP7, BNIP3, CA9, CAT, CBS, CCNB1, CCS, CD34, CD36, CDK1, CDK2, CITED2, CMA1, CPA3, CREBBP, CRYGD, CST3, CTSD, CTSG, CTSZ, CUL2, DPEP1, DUOX1, DUOX2, E2F1, ECT2, EGLN1, EGLN2, EGLN3, EGR1, ENPEP, EP300, EPAS1, EPO, EPX, ETS1, FABP1, FAM162A, FANCC, FBLN5, FER, FIGF, FLT1, FLT4, FMN2, FNDC1, FOS, FOXO1, FXN, GATA6, GNB1, GNGT1, GPX1, GPX3, GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, GZMH, HBA1, HBB, HDAC6, HGF, HIF1A, HIF1AN, HIF3A, HIPK2, HMOX1, HP, ICAM1, IL18, IL18BP, IL6, IRAK1, IREB2, ITPR1, KCNK3, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KDR, KLF2, LCN2, LMNA, LPO, MAP3K5, MAPK7, MDM2, MDM4, MET, MGARP, MME, MPO, MPV17, MRVI1, MT3, MTOR, MYOCD, NDRG1, NET1, NFE2L2, NKX3-1, NOS1, NOS2, NOS3, NOTCH1, NPEPPS, NRP1, NRP2, PARK7, PAX2, PDE10A, PDE11A, PDE1A, PDE1B, PDE2A, PDE3A, PDE3B, PDE5A, PDE6A, PDE6B, PDE6G, PDE9A, PDGFC, PDIA2, PDK1, PDK2, PDK3, PGF, PKD2, PLEKHA1, PLK3, PMAIP1, PPARGC1B, PPIF, PRDX1, PRDX2, PRDX3, PRDX5, PRDX6, PRKAA1, PRKCE, PRKG1, PRKG2, PTGIS, PTGS2, PTPRK, PXDN, PXDNL, PXN, RBX1, REN, RGCC, RHOB, ROMO1, RPS27A, S100B, SFRP1, SFTPC, SIRT1, SLC29A1, SLC8A1, SOD1, SOD2, SOD3, STC1, STC2, TCEB1, TCEB2, TNFAIP3, TP53, TPM1, TPO, TWIST1, TXNRD1, UBA52, UBB, UBC, UBE2D1, UBE2D2, UBE2D3, UBQLN1, UCN2, UCN3, USP19, VEGFA, VEGFB, VEGFC, VHL*.

Functional analysis of selected genes
-------------------------------------

We assessed the genes in the top 1% windows of iHS, XP-EHH, and PBS to identify possible enrichment of functional categories by gene ontology (GO) terms. Among the GO terms, two were related to NO and four were involved in stress response (Table[5](#tbl5){ref-type="table"}). Eleven GO terms were involved in synaptic activity, neuronal structure, neuron differentiation or related to the inhibitory neurotransmitter *γ*-aminobutyric acid (GABA) (Table[5](#tbl5){ref-type="table"}).

###### 

Subset of enriched GO terms of iHS and XP-EHH results in Calchaquíes

  Test (enriched GO terms)                       Category                                      GO term                                             Enrichment   EASE score
  ---------------------------------------------- --------------------------------------------- --------------------------------------------------- ------------ ------------
  iHS (115)                                      Nitrogen related                              Regulation of nitrogen compound metabolic process   38/1950      0.0055
  Cellular nitrogen compound metabolic process   42/2254                                       0.0063                                                           
  Stress response                                Response to biotic stimulus                   14/355                                              0.0008       
  Response to DNA damage stimulus                14/379                                        0.0015                                                           
  Defense response                               17/534                                        0.0016                                                           
  Response to stress                             29/1374                                       0.0082                                                           
  Neuron related                                 Regulation of neuron projection development   9/168                                               0.0020       
  Regulation of neurogenesis                     11/307                                        0.0078                                                           
  Regulation of neuron differentiation           10/260                                        0.0080                                                           
  XP-EHH (25)                                    Neuron related                                Synaptic transmission, gabaergic                    4/4          0.0001
  Postsynaptic membrane                          9/164                                         0.0009                                                           
  GABA-A receptor activity                       4/16                                          0.0013                                                           
  GABA signaling pathway                         4/17                                          0.0016                                                           
  GABA receptor activity                         4/19                                          0.0021                                                           
  Synaptic membrane                              9/191                                         0.0023                                                           
  Neuron--neuron synaptic transmission           5/44                                          0.0024                                                           
  PBS (27)                                       Neuron related                                Neuron differentiation                              2.4          0.0053

Genotype--phenotype associations
--------------------------------

Genotype--phenotype associations were calculated for the SNP in the *PRKG1* intron that had the highest PBS score within the 5th ranking window. Even though we did not assess NO levels, cardiovascular measurements such as blood pressure and heart rate could be affected by differential vasodilation. However, we found no significant correlation between these traits and the allele frequency of the *PRKG1* intronic SNP.

Signatures of selection at intermediate and high altitude
---------------------------------------------------------

We compared the results of the four selection tests of IA Calchaquíes to our previous findings in the neighboring HA Colla population (Eichstaedt et al. [@b23]). Overall, the high genome-wide similarity among Collas and Calchaquíes was also reflected in the relatively high sharing of windows in the top 5% (Fig.[4](#fig04){ref-type="fig"}). Despite this high window overlap between Calchaquíes (IA) and Collas (HA) only two candidate genes were shared: *PRKG1* and *CBS*.

![Overlap of the top 1% selection test results in Calchaquíes and with the top 5% in Collas. The overlap of windows highlighted by selection tests was the highest for *F*~ST~ with 60%. However, only two out of 213 candidate genes (*PRKG1* and *CBS*) overlapped, both discovered using PBS. *PRKG1* ranked higher in Calchaquíes with a PBS score of 0.836 (rank 5) than in Collas with a score of 0.693 (rank 52). Thus, allele frequencies were more diverged in Calchaquíes than in Collas. The PBS score is based on the same SNP (rs10740406) for both populations. *CBS* ranked lower in Calchaquíes (rank 48, PBS score 0.632) than in Collas (rank 2, PBS score 1.005), indicating a less pronounced allele differentiation in Calchaquíes in comparison to Collas for this gene. For *CBS* different SNPs within the same 100 kb window were highlighted in the two populations. *CBS*, cystathionine-beta-synthase; *F*~ST~, Fixation Index; iHS, integrated Haplotype Score; PBS, Population Branch Score; *PRKG1*, protein kinase, cGMP-dependent, type I; XP-EHH, Cross Population Extended Haplotype Homozygosity test.](phy20003-e12376-f4){#fig04}

We found some indication of reduced selection pressure at moderate hypoxia in the genome-wide signatures of Calchaquíes (IA). First, 61 genes were highlighted by more than one test in Calchaquíes (data not shown), in contrast to 108 in Collas (HA). Second, pairwise *F*~ST~ resulted in 17 *F*~ST~ windows in Calchaquíes above a cut-off of *F*~ST~ = 0.6, compared to 40 windows in Collas. Lastly, of the PBS windows overlapping in the top 1% of Calchaquíes and Collas only 22% of Calchaquí branch lengths exceeded those of Collas (*PRKG1* included) indicating a stronger selection pressure in Collas for 78% of commonly highlighted genes. Taken together, these results suggest different strengths of hypoxia-driven selection are acting upon the genome of each population, resulting in weaker signatures at intermediate altitude.

Discussion
==========

Our aim was to investigate biological adaptation to moderate levels of hypoxia at intermediate altitude (IA) and to characterize the phenotypic and genetic changes that are likely a response to this specific environmental pressure. There is limited evidence of adaptation by natural selection in the genome of Calchaquíes (IA) and support for at least developmental plasticity at the phenotypic level.

Admixture analyses (Fig.[2](#fig02){ref-type="fig"}) suggest that all Andean populations included in this study (HA: Quechua, Aymara, Collas; IA: Diaguita, and Calchaquíes) share a highly homogenous genetic makeup, compared to other Native Americans. This is consistent with recently shared ancestry, gene flow or both. However, despite being highly homogeneous, these different Andean groups also display some level of geographic differentiation (Fig.[3](#fig03){ref-type="fig"}). While the two Argentinean groups are closer to each other than either is to Peruvian or Bolivian highlanders, a rough distinction between the two populations is still possible (Fig.[3](#fig03){ref-type="fig"}).

European admixture in Calchaquíes (IA) was low (Table[1](#tbl1){ref-type="table"}) both at the autosomal level (9%) as well as in the mtDNA (none) and Y-chr (20%). In contrast, a study of urban Argentinean populations estimated European admixture to be around 80% in the autosome, 45% in the mtDNA, and even 95% in the Y-chr (Corach et al. [@b21]).

The effect of moderate hypoxia on the phenotype was assessed using anthropometric and physiological data. Calchaquíes\' stature (IA) is comparable to that of Wichí (LA) and Collas (HA). While short stature is expected in the HA group, the reduced growth in the LA sample may be explained by nutrition and disease (Frisancho et al. [@b31]), and the general poorer health status observed among Wichí. The stature of a group of Turkish children living at similar intermediate altitude was shown to be significantly shorter in comparison to a lowland control group (Malkoc et al. [@b43]). This might indicate influence of moderate hypoxia on growth patterns while also socioeconomic factors and different growth spurt patterns in children may play a role.

While overall stature was similar in our study, we observed differences in distal limbs length, this being similar between Calchaquíes (IA) and Wichí (LA) but significantly shorter in Collas (HA). While cold has been suggested to reduce the overall length of limb segments (Allen [@b4]; Katzmarzyk and Leonard [@b40]), hypoxia likewise exerts a strong effect upon these traits (de Meer et al. [@b46]; Tripathy and Gupta [@b68]). The tibia is more susceptible to periods of poorer health than the femur (Bogin and Varela-Silva [@b14]), thus also reduced oxygen supply is likely to impact bone growth at a critical time during development (Bailey and Hu [@b5]). Reduced tibia length was also observed among Tibetan and Peruvian children at HA (Stinson and Frisancho [@b65]; Bailey and Hu [@b5]; Pomeroy et al. [@b53]), the latter also showing reduction of forearm length. This suggests hypoxia\'s effect on distal limb segments, though other climatic factors cannot be excluded. In Calchaquíes (IA), exposure to moderate hypoxia and milder climate (Bianchi and Cravero [@b10]) may exert a weaker pressure on bone growth than in Collas (HA). Their reduction in distal limb lengths, however, may not be adaptive per se but may indicate the prioritization of oxygen use throughout the organism (Pomeroy et al. [@b53]), alongside other physiological strategies such as the increased hematocrit, which although was not measured in our sample, is well documented among Andeans (Frisancho [@b28]; Engström et al. [@b24]). While tibia and forearm length reduction was only observed in highland Collas, lung volume was increased in Collas and Calchaquíes (IA) alike (Table[3](#tbl3){ref-type="table"}). Increased lung capacity is one of the typical Andean adaptive characteristics and it is thought to be a developmental consequence of early exposure to hypoxia (Frisancho [@b30]), though genetic factors may also be at play as suggested by the significant differences in forced vital capacity (FVC) that exist between native highlanders, acclimatized Europeans, and Europeans raised at HA (Brutsaert et al. [@b16]).

Shared ancestry between HA and IA Andeans may confound evidence of positive selection. However, despite the extensive genomic similarity (Figs.[3](#fig03){ref-type="fig"}), we identified only two shared candidate genes (*CBS* and *PRKG1*). In particular, *PRKG1* is our strongest candidate of selection at IA; however, we could not correlate this gene with any of the phenotypic traits observed. This may be due to our decision not to measure NO-induced vasodilation due to feasibility concerns during the research design.

We also found little overlap with selection signals previously reported for Aymara or Quechua (Bigham et al. [@b11], [@b12]). This could be the result of differences in the genotyping platform used, the statistics employed, or the choice of control population. Alternatively, our results may confirm different selection patterns among Andeans. We found only one gene candidate gene overlapping (EPO) with genes highlighted Tibetans (Bigham et al. [@b12]) and no common candidate gene in Ethiopians and Calchaquíes (IA).

The argument that hypoxia adaptation at IA is at least partly facilitated by genetic changes clearly needs supportive evidence from further studies. The finding of hypoxia related genes, such as *PRKG1*, among our topmost ranking genes of the selection tests suggests that candidate genes of HA adaptation may be found in IA populations. However, these preliminary results need to be followed up firstly, by sequencing studies to determine the likely causative mutations and subsequently by functional characterization of these polymorphisms. The approaches we have used here, while able to identify outlier regions of the genomes by genetic differentiation or extent of homozygosity, are to be considered with caution as the false positive rates can be high in populations with small effective population sizes (Charlesworth [@b19]). This is particularly due to genetic drift in isolated populations. However, Calchaquíes showed the highest heterozygosity levels among Native Americans and thus genetic drift may be a lesser concern in this population. Another limitation is the risk of confounding results due to the SNP ascertainment bias typical of genotyping methodologies (Clark et al. [@b20]). Whole genome sequencing should overcome this limitation. In addition, polygenic traits and alleles with slowly changing frequencies may also contribute to the genomic signatures (Pritchard et al. [@b55]) and are unlikely to be identified by the selection tests employed here.

Despite these limitations, our analyses identified *PRKG1* and two pathways associated with NO metabolism (Tables[4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}) as strong follow-up candidates. Interestingly, Bigham et al. ([@b11], [@b12]) identified the inducible NO synthase as a target of selection in Aymara and Quechua. Notably, *PRKG1* was recently identified as a target of selection in Siberians (Cardona et al. [@b18]). The same region highlighted by PBS in this study was highlighted by XP-EHH in the North East Siberians (Chukchi, Eskimo, and Koryaks). However, high-frequency Calchaquí alleles showed only frequencies around 50% or lower in the three Siberian populations and therefore no strong case for introgression can be made. While NO is implicated in various physiological mechanisms, such as cold-induced smooth muscle constriction in Siberians, the mild climate of the Calchaquí valleys and the moderate level of hypoxia support a hypoxia-driven signal in Calchaquíes (IA). In addition, four pathways associated with the neurotransmitter GABA were significantly enriched among the top 1% XP-EHH results (Table[5](#tbl5){ref-type="table"}). GABA is increased during hypoxia (Wood et al. [@b73]) and protects neurons against ischemic damage (Fern et al. [@b26]), thus selection on GABA pathways may result in protection for the hypoxic brain.

While the overall findings of selection tests revealed only one strong candidate gene, some indicators of reduced selection pressure compared to HA Collas were observed in Calchaquíes (IA). However, we also observed shared selection signals between Collas (HA) and Calchaquíes (IA), either due to the common pressure of hypoxia or to their shared demographic history (Fig.[3](#fig03){ref-type="fig"}). To elucidate the causal factor, further comparisons of neighboring populations would be necessary.

In summary, our study suggests that developmental plasticity and/or genetic changes develop in response to even moderate hypoxia, despite the relatively recent ancestry and thus short-term exposure (in evolutionary terms) of Calchaquíes to their environment. Hence, populations living at IA (2000--3000 m) should also be considered when exploring human adaptability to hypobaric hypoxia to further elucidate influences of this selection pressure.
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